Reaction

Osteosarcoma Metastatic reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 95 reports · 3 co-occurring drugs

As of the last recalculation, Osteosarcoma Metastatic appears in 95 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is REGORAFENIB (PRR 234.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Regorafenib11234.6234.9
Pazopanib Hydrochloride16155.6155.7
Ifosfamide10113.9113.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.